US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 0.385
  • +0.005+1.18%
Close Nov 22 16:00 ET
  • 0.387
  • +0.003+0.75%
Post 19:28 ET
6.64MMarket Cap-444P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-59.24%2.15M
17.99%5.11M
-32.16%3.26M
5.37%18.5M
-20.37%4.07M
22.90%5.28M
-7.24%4.33M
38.55%4.81M
198.89%17.55M
82.78%5.11M
Selling and administrative expenses
-52.33%938.03K
-5.78%2.03M
-33.37%1.53M
-14.84%7.15M
-73.87%733.96K
3.04%1.97M
3.34%2.16M
43.89%2.3M
147.31%8.4M
65.15%2.81M
-General and administrative expense
-52.33%938.03K
-5.78%2.03M
-33.37%1.53M
-14.84%7.15M
-73.87%733.96K
3.04%1.97M
3.34%2.16M
43.89%2.3M
147.31%8.4M
65.15%2.81M
Research and development costs
-63.28%1.23M
3.90%3.08M
-32.12%1.76M
19.85%12.26M
25.19%3.36M
9.81%3.34M
13.20%2.97M
37.72%2.59M
271.55%10.23M
109.00%2.69M
Other operating expenses
56.44%-11.95K
----
65.93%-27.06K
14.57%-923.04K
92.90%-27.25K
95.81%-27.44K
-2,171.63%-788.94K
-1,036.04%-79.41K
-288.18%-1.08M
-102.47%-383.77K
Operating profit
59.24%-2.15M
-17.99%-5.11M
32.16%-3.26M
-5.37%-18.5M
20.37%-4.07M
-22.90%-5.28M
7.24%-4.33M
-38.55%-4.81M
-198.89%-17.55M
-82.78%-5.11M
Net non-operating interest income expense
38.12%-10.61K
43.35%-4.3K
-10.15%-9.54K
-337.23%-50.61K
23.01%-17.21K
-290.55%-17.15K
-670.77%-7.6K
-2,059.05%-8.66K
87.74%-11.58K
-4,482.35%-22.35K
Non-operating interest income
36.64%179
-27.64%178
-96.48%168
-74.11%5.29K
-98.58%137
-98.54%131
-81.52%246
979.19%4.77K
2,973.80%20.41K
1,789.41%9.64K
Non-operating interest expense
-37.55%10.79K
-42.85%4.48K
-27.72%9.71K
74.76%55.9K
--17.35K
--17.28K
--7.84K
--13.43K
-66.36%31.99K
----
Other net income (expense)
-157.32K
-72.59K
-55.35K
Gain on sale of security
---157.32K
---72.59K
---55.35K
----
----
----
----
----
----
----
Income before tax
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Income tax
Net income
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Net income continuous Operations
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Minority interest income
Net income attributable to the parent company
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.20%-2.32M
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
Basic earnings per share
99.67%-0.16
99.48%-0.74
99.75%-0.65
90.43%-103.61
97.94%-6.5146
81.68%-48.44
50.56%-142.38
-19.94%-259.07
-67.10%-1.08K
-82.31%-316.39
Diluted earnings per share
99.67%-0.16
99.48%-0.74
99.75%-0.65
90.43%-103.61
97.94%-6.5146
81.68%-48.44
50.56%-142.38
-19.94%-259.07
-67.10%-1.08K
-82.31%-316.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -59.24%2.15M17.99%5.11M-32.16%3.26M5.37%18.5M-20.37%4.07M22.90%5.28M-7.24%4.33M38.55%4.81M198.89%17.55M82.78%5.11M
Selling and administrative expenses -52.33%938.03K-5.78%2.03M-33.37%1.53M-14.84%7.15M-73.87%733.96K3.04%1.97M3.34%2.16M43.89%2.3M147.31%8.4M65.15%2.81M
-General and administrative expense -52.33%938.03K-5.78%2.03M-33.37%1.53M-14.84%7.15M-73.87%733.96K3.04%1.97M3.34%2.16M43.89%2.3M147.31%8.4M65.15%2.81M
Research and development costs -63.28%1.23M3.90%3.08M-32.12%1.76M19.85%12.26M25.19%3.36M9.81%3.34M13.20%2.97M37.72%2.59M271.55%10.23M109.00%2.69M
Other operating expenses 56.44%-11.95K----65.93%-27.06K14.57%-923.04K92.90%-27.25K95.81%-27.44K-2,171.63%-788.94K-1,036.04%-79.41K-288.18%-1.08M-102.47%-383.77K
Operating profit 59.24%-2.15M-17.99%-5.11M32.16%-3.26M-5.37%-18.5M20.37%-4.07M-22.90%-5.28M7.24%-4.33M-38.55%-4.81M-198.89%-17.55M-82.78%-5.11M
Net non-operating interest income expense 38.12%-10.61K43.35%-4.3K-10.15%-9.54K-337.23%-50.61K23.01%-17.21K-290.55%-17.15K-670.77%-7.6K-2,059.05%-8.66K87.74%-11.58K-4,482.35%-22.35K
Non-operating interest income 36.64%179-27.64%178-96.48%168-74.11%5.29K-98.58%137-98.54%131-81.52%246979.19%4.77K2,973.80%20.41K1,789.41%9.64K
Non-operating interest expense -37.55%10.79K-42.85%4.48K-27.72%9.71K74.76%55.9K--17.35K--17.28K--7.84K--13.43K-66.36%31.99K----
Other net income (expense) -157.32K-72.59K-55.35K
Gain on sale of security ---157.32K---72.59K---55.35K----------------------------
Income before tax 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Income tax
Net income 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Net income continuous Operations 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Minority interest income
Net income attributable to the parent company 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.20%-2.32M-19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M
Basic earnings per share 99.67%-0.1699.48%-0.7499.75%-0.6590.43%-103.6197.94%-6.514681.68%-48.4450.56%-142.38-19.94%-259.07-67.10%-1.08K-82.31%-316.39
Diluted earnings per share 99.67%-0.1699.48%-0.7499.75%-0.6590.43%-103.6197.94%-6.514681.68%-48.4450.56%-142.38-19.94%-259.07-67.10%-1.08K-82.31%-316.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data